Saipen Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in Patna, Bihar, India, established in 2011.

2011 Patna, Bihar, India Active

Last Updated: February 09, 2026

About Saipen Pharmaceuticals Private Limited

Saipen Pharmaceuticals Private Limited, a active private limited company, was established on 23 August 2011 in Patna, Bihar, India. Engaging in other wholesale within the trade sector, it holds CIN: U24231BR2011PTC017360. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹0.30 M and a paid-up capital of ₹0.20 M.

It upholds a compliant status. Its leadership includes Sheo Shankar Gupta (Director), Ajay Kumar (Director), Anu Kumari (Additional Director). Its latest AGM occurred on 10 September 2019, with the balance sheet filed on 31 March 2019. It is based at C/O Ranu Sah, Sanjay Nagar, Road No.-10 South Of Postal Park, Gpo, Patna, Bihar, 800001.

Company Details

CIN/LLPIN
U24231BR2011PTC017360
Registration Number
017360
Incorporation Date
23 August 2011
Authorized Capital
₹0.30 M
Paid-Up Capital
₹0.20 M
ROC Code
Roc Patna
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 0.30 M as on 09-02-2026
Paid Up Capital ₹ 0.20 M as on 09-02-2026
Company Age 14 Year, 6 Months
Last Filing with ROC 31 Mar 2019
Revenue Growth **** -60.32% (FY 2017)
Profit Growth **** 31.73% (FY 2017)
Ebitda **** -94.82% (FY 2017)
Net Worth -5.08% (FY 2017)
Total Assets -51.53% (FY 2017)

Comprehensive Company Insights

Explore comprehensive insights into Saipen Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Saipen Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Sheo Shankar Gupta	Director	23 Aug 2011	Current
Ajay Kumar	Director	23 Aug 2011	Current
Anu Kumari	Additional Director	27 Apr 2013	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Saipen Pharmaceuticals.

Saipen Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 60.32% decrease. The company also saw a substantial improvement in profitability, with a 31.73% increase in profit. The company's net worth dipped by a decrease of 5.08%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-60.32%

*******

Revenue from Operations

*******

-60.32%

*******

Total Assets

*******

-51.53%

*******

Profit or Loss

*******

31.73%

*******

Net Worth

*******

-5.08%

*******

EBITDA

*******

-94.82%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Saipen Pharmaceuticals?

In 2017, Saipen Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Saipen Pharmaceuticals?

Unlock and access historical data on people associated with Saipen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Saipen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saipen Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Saipen Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

The activity Saipen Pharmaceuticals Private Limited last Annual general meeting of members was held on 10 Sep 2019 as per latest MCA records. was completed.
10 Sep 2019
Balance Sheet

Progress on Saipen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Patna. was documented.
31 Mar 2019
Director Appointment

Anu Kumari was appointed as a Additional Director was appointed as a Additional Director on 27 Apr 2013 & has been associated with this company since 12 years 9 months . was recorded as a recent event.
27 Apr 2013
Director Appointment

Progress on Sheo Shankar Gupta was appointed as a Director was appointed as a Director on 23 Aug 2011 & has been associated with this company since 14 years 6 months . was documented.
23 Aug 2011
Director Appointment

Ajay Kumar was appointed as a Director was appointed as a Director on 23 Aug 2011 & has been associated with this company since 14 years 6 months . was recorded as a recent event.
23 Aug 2011
Company Incorporation

The activity Saipen Pharmaceuticals Private Limited was registered on 23 Aug 2011 with Roc Patna & aged 14 years 6 months as per MCA records. was completed.
23 Aug 2011

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Saipen Pharmaceuticals Private Limited?

The CIN of Saipen Pharmaceuticals Private Limited is U24231BR2011PTC017360.

Where is Saipen Pharmaceuticals Private Limited headquartered?

Saipen Pharmaceuticals Private Limited is headquartered at C/O Ranu Sah, Sanjay Nagar, Road No.-10 South Of Postal Park, Gpo, Patna, Bihar, 800001.

When was Saipen Pharmaceuticals Private Limited incorporated?

Saipen Pharmaceuticals Private Limited was incorporated on 23 August 2011.

Who are the current directors of Saipen Pharmaceuticals Private Limited?

The current directors of Saipen Pharmaceuticals Private Limited are

What is the primary industry of Saipen Pharmaceuticals Private Limited?

The primary industry of Saipen Pharmaceuticals Private Limited is Trade.

Is Saipen Pharmaceuticals Private Limited a listed company?

Saipen Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Saipen Pharmaceuticals Private Limited?

The authorized capital of Saipen Pharmaceuticals Private Limited is ₹0.30 M, and the paid-up capital is ₹0.20 M.

What is the compliance status of Saipen Pharmaceuticals Private Limited?

The compliance status of Saipen Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available